Icon

Mayzent - (0.25mg, 1mg, 2 mg Tablet)

Siponimod Fumaric Acid Novartis
0.25mg, 1mg, 2 mg Tablet
Less Than $1000 mn
None None
More Than 5
None
None None
MAYZENT is a sphingosine 1-phosphate (S1P) receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Yes
*** ******* ** *** **, ****.
Mayzent Patent 1 Patent 2
** *******
  1. *** **, **** : * ****-** ** ***** *** ***** *** **** *** *********.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.